1.
Clinical Study of the Expression of Tissue Factor and Urokinase Plasminogen Activator Receptor in Breast Cancer
组织因子、尿激酶型纤溶酶原激活剂受体在乳腺癌中的表达
2.
Plasma Concentrations Changes and Significance of Plasminogen Activator, Plasminogen Activator Receptor and Plasminogen Activator Inhibitor-1 in Chronic Glomerulonephritis and the Intervenient Research on Them;
慢性肾小球肾炎血浆纤溶酶原激活物及其受体和纤溶酶原激活物抑制剂的变化与干预研究
3.
Comparison of Recombinant Tissue Plasminogen Activator, Urokinase and Defibrase in Vitro Simulation of Thrombolytic Test
重组织型纤溶酶原激活剂、尿激酶和降纤酶体外溶栓效果比较
4.
DETERMINATION OF THE PLASMINOGEN ACTIVATOR IN THE TONSIL OF CHRONIC TONSILLITIS
慢性扁桃体炎组织中的纤溶酶原激活剂测定
5.
Clinical Significance of Measurement of Plasma Urokinase Type Plasminogen Activator and its Receptor in Cancer Patients
癌症患者尿激酶型纤溶酶原激活物及其受体检测的临床意义
6.
The Relationship between the Expression of Yrokinase-type Plasminogen Activator Receptor,and the Infiltration and Metastasis of Gastric Cancer
尿激酶型纤溶酶原激活物受体表达与胃癌浸润和转移过程的关系
7.
Expression of urokinase-type plasminogen activator and its receptor protein in synovial tissues from osteoarthritis
骨关节炎滑膜中尿激酶型纤溶酶原激活物及其受体蛋白的表达
8.
Study on Recombinant Nonglycosylated Urokinase-type Plasminogen Activator;
重组非糖基化尿激酶型纤溶酶原激活剂的研究
9.
recombinant human plasminogen
重组体人纤溶酶原激活质
10.
Construction of Tissue-type Plasminogen Activator Variants and Their Expression in Prokaryotic and Eukaryotic Cells;
组织型纤溶酶原激活剂（t-PA）突变体的构建及其表达研究
11.
Construction of Eukaryotic Expessing Vector of Tissue Plasminogen Activator (t-PA);
组织型纤溶酶原激活剂（t-PA）真核表达载体的构建
12.
Detection and clinical significance of plasma urokinase-type plasminogen activator and its soluble receptor in multiple myeloma patients;
多发性骨髓瘤患者血浆尿激酶型纤溶酶原激活物及其可溶性受体的检测
13.
Study of Plasminogen Activerin Agkistrodon Halysussuriensis Venom;
长白白眉蝮蛇蛇毒中纤溶酶原激活剂的研究
14.
Antithrombotic Effect of a Plasminogen Activator from Gloydius Brevicaudus Venom;
短尾蝮蛇毒纤溶酶原激活剂的抗栓作用研究
15.
Plasminogen Activator Inhibitor-1 and Cardiovascular Diseases
纤溶酶原激活物抑制剂-1与心血管疾病
16.
Inhibitory effect of green tea polyphenols on plasminogen activator inhibitor-1 expression
绿茶多酚对纤溶酶原激活物抑制剂-1表达影响
17.
Expression and Regulation of Urokinase-type Plasminogen Activator in Supraglottic Laryngeal Cancer;
尿激酶型纤溶酶原激活剂在声门上型喉癌中的表达及调节机制
18.
Significance of Urokinase-type Plasminogen Activator and Urokinase-type Plasminogen Activator Receptor in Synovial Fluid of Patients with Temporomandibular Disorders;
颞下颌关节紊乱病关节液中尿激酶型纤溶酶原激活物及其受体的检测